{"id":94953,"date":"2026-05-22T14:15:56","date_gmt":"2026-05-22T08:45:56","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=94953"},"modified":"2026-05-22T14:15:58","modified_gmt":"2026-05-22T08:45:58","slug":"link-pharmachem-q4-fy26-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/","title":{"rendered":"Link Pharmachem Q4 FY26 Results: PAT Rs 0.55 Cr"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p><strong><a href=\"https:\/\/univest.in\/user\/stocks\/linkph\/link-pharma-chem-ltd-share-price-today\">Link Pharmachem<\/a> Q4 FY26<\/strong> results were declared on May 21, 2026. The company reported PAT of Rs 0.55 crore for the quarter ended March 31, 2026, up 14.6% YoY compared to Rs 0.48 crore in Q4 FY25. Revenue from operations stood at Rs 6.59 crore, up 2.2% YoY. Results are on a Standalone basis. Link Pharmachem is a Pharmaceutical Chemicals company listed on Indian stock exchanges.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\">Click Here \u2013 Get Free Investment Predictions<\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Link_Pharmachem_Q4_FY26_Financial_Highlights\" title=\"Link Pharmachem Q4 FY26 Financial Highlights\">Link Pharmachem Q4 FY26 Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Link_Pharmachem_Q4_FY26_Performance_Analysis\" title=\"Link Pharmachem Q4 FY26 Performance Analysis\">Link Pharmachem Q4 FY26 Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Key_Factors_Driving_Link_Pharmachem_Q4_FY26_Results\" title=\"Key Factors Driving Link Pharmachem Q4 FY26 Results\">Key Factors Driving Link Pharmachem Q4 FY26 Results<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Revenue_and_Operational_Performance\" title=\"Revenue and Operational Performance\">Revenue and Operational Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Profitability_Trends\" title=\"Profitability Trends\">Profitability Trends<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Sector_and_Macro_Context\" title=\"Sector and Macro Context\">Sector and Macro Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#FY27_Outlook\" title=\"FY27 Outlook\">FY27 Outlook<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Frequently_Asked_Questions_on_the_company\" title=\"Frequently Asked Questions on the company\">Frequently Asked Questions on the company<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#What_is_Link_Pharmachem_Q4_FY26_net_profit\" title=\"What is Link Pharmachem Q4 FY26 net profit?\">What is Link Pharmachem Q4 FY26 net profit?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#What_is_Link_Pharmachem_Q4_FY26_revenue\" title=\"What is Link Pharmachem Q4 FY26 revenue?\">What is Link Pharmachem Q4 FY26 revenue?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#When_were_Link_Pharmachem_Q4_FY26_results_declared\" title=\"When were Link Pharmachem Q4 FY26 results declared?\">When were Link Pharmachem Q4 FY26 results declared?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/link-pharmachem-q4-fy26-results\/#Is_Link_Pharmachem_a_good_investment_after_Q4_FY26\" title=\"Is Link Pharmachem a good investment after Q4 FY26?\">Is Link Pharmachem a good investment after Q4 FY26?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Link_Pharmachem_Q4_FY26_Financial_Highlights\"><\/span><strong>Link Pharmachem Q4 FY26 Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q4 FY26 (Rs Cr)<\/th>\n<th>Q4 FY25 (Rs Cr)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 6.59 crore<\/td>\n<td>Rs 6.45 crore<\/td>\n<td>+2.2%<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit<\/strong><\/td>\n<td>0.55<\/td>\n<td>0.48<\/td>\n<td>+14.6%<\/td>\n<\/tr>\n<tr>\n<td><strong>Basis<\/strong><\/td>\n<td colspan=\"3\">Standalone<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><em>Note: Q4 FY26 standalone revenue Rs 6.59 crore (+2.21% YoY). Pharmaceutical and specialty chemicals manufacturer. Verify from BSE\/NSE audited filings before investment decisions.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Link_Pharmachem_Q4_FY26_Performance_Analysis\"><\/span><strong>Link Pharmachem Q4 FY26 Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Link Pharmachem Q4 FY26<\/strong> results reflect the company&#8217;s operational performance during the January to March 2026 quarter. The company delivered results in line with its sector trends during the quarter. Link Pharmachem operates in the Pharmaceutical Chemicals sector, benefiting from India&#8217;s GDP growth above 6.5% in FY26 and sustained domestic demand conditions.<\/p>\n<p>Revenue of Rs 6.59 crore was up 2.2% YoY. Steady revenue momentum reflects consistent business conditions.<\/p>\n<p><a href=\"https:\/\/univest.in\/screeners\">Screen the best stocks on the Univest Screener.<\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_Driving_Link_Pharmachem_Q4_FY26_Results\"><\/span><strong>Key Factors Driving Link Pharmachem Q4 FY26 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Revenue_and_Operational_Performance\"><\/span><strong>Revenue and Operational Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Revenue of Rs 6.59 crore in Link Pharmachem Q4 FY26 was up 2.2% YoY. Revenue performance reflects stable demand conditions. The January to March period is the year-end quarter for Indian companies, characterised by strong execution cycles, project completions, and fiscal year-end activity.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profitability_Trends\"><\/span><strong>Profitability Trends<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Link Pharmachem Q4 FY26 PAT of Rs 0.55 crore up 14.6% YoY. Stable profitability reflects consistent operational delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Sector_and_Macro_Context\"><\/span><strong>Sector and Macro Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s macro environment in Q4 FY26 was supportive, with GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore budgeted for FY27, and resilient domestic consumption. The Pharmaceutical Chemicals sector saw broadly constructive demand conditions. For Link Pharmachem, these macro tailwinds provided a supportive backdrop entering FY27.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Outlook\"><\/span><strong>FY27 Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Following the firm results, management commentary on FY27 revenue guidance, margin improvement trajectory, and capital allocation priorities will be the key investor watchpoints. The Pharmaceutical Chemicals sector continues to benefit from India&#8217;s structural growth drivers. Delivering consistent growth and margin expansion remains the strategic priority.<\/p>\n<p>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to get daily stock recommendations and expert research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_the_company\"><\/span><strong>Frequently Asked Questions on the company<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Link_Pharmachem_Q4_FY26_net_profit\"><\/span><strong>What is Link Pharmachem Q4 FY26 net profit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> <strong>Link Pharmachem Q4 FY26<\/strong> PAT of Rs 0.55 crore, up 14.6% YoY from Rs 0.48 crore in Q4 FY25. Results declared May 21, 2026, on a Standalone basis. Verify from BSE\/NSE audited filings.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Link_Pharmachem_Q4_FY26_revenue\"><\/span><strong>What is Link Pharmachem Q4 FY26 revenue?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Link Pharmachem Q4 FY26 revenue from operations was Rs 6.59 crore, up 2.2% YoY. Verify from BSE\/NSE filings for complete audited breakdown.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"When_were_Link_Pharmachem_Q4_FY26_results_declared\"><\/span><strong>When were Link Pharmachem Q4 FY26 results declared?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Link Pharmachem Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.<\/p>\n<\/div>\n<\/div>\n<div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Link_Pharmachem_a_good_investment_after_Q4_FY26\"><\/span><strong>Is Link Pharmachem a good investment after Q4 FY26?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<div>\n<p><strong>Ans.<\/strong> Investment decisions require individual assessment of fundamentals, valuation, and risk tolerance. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing in Link Pharmachem.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p><em>Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Verify all figures from BSE\/NSE filings. Consult a SEBI-registered financial advisor.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Link Pharmachem Q4 FY26 results May 21 2026. PAT of Rs 0.55 crore up 14.6% YoY. Revenue Rs 6.59 crore. Full analysis.<\/p>\n","protected":false},"author":26,"featured_media":95092,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-94953","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1779439567:26"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["79"],"rank_math_focus_keyword":["Link Pharmachem Q4"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Link Pharmachem Q4 FY26 Results: PAT Rs 0.55 Cr"],"rank_math_description":["Link Pharmachem Q4 FY26 results May 21 2026. PAT of Rs 0.55 crore up 14.6% YoY. Revenue Rs 6.59 crore. Full analysis."],"_thumbnail_id":["95092"],"_edit_last":["26"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["13035"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/05\/22141532\/Link-Pharmachem-Q4-FY26-Results.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/94953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=94953"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/94953\/revisions"}],"predecessor-version":[{"id":95093,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/94953\/revisions\/95093"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/95092"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=94953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=94953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=94953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}